Skip to main content
PepStack
Blutwerte · Marker

Oxidiertes LDL

Oxidized LDL · oxLDL · ox-LDL

Lipide & Herz-Kreislauf
Einheit:
mg/dL
Abbreviation
oxLDL

Oxidized LDL measures the level of oxidatively modified low-density lipoprotein in the blood.

Reference Ranges

Reference
0.51.5mg/dL
0.5
1.5
LowNormalHigh
Reference
Unit · mg/dL

Reference ranges may vary by laboratory and are not well standardized.

Overview

Übersicht

Oxidized LDL (oxLDL) is a modified form of low-density lipoprotein that has undergone oxidative modification. It is a key player in the pathogenesis of atherosclerosis, a chronic inflammatory disease characterized by the accumulation of lipids and inflammatory cells within arterial walls. Researchers have found that oxLDL is taken up by macrophages through scavenger receptors, such as LOX-1, leading to the formation of foam cells, which are crucial in the development of atherosclerotic plaques. Clinically, elevated oxLDL levels are associated with increased risk of cardiovascular diseases, including coronary artery disease and stroke. It reflects the oxidative stress and inflammatory status within the body, serving as a biomarker for atherosclerotic disease progression. In the context of athletic performance and biohacking, maintaining low oxLDL levels may contribute to cardiovascular health and longevity. However, the direct impact on athletic performance is less clear, as it primarily serves as an indicator of cardiovascular risk rather than a performance metric. Caveats include potential confounders such as diet, smoking, and underlying metabolic conditions that can influence oxLDL levels. Fasting status and time of day may not significantly affect oxLDL measurements, but consistent testing conditions are recommended for accurate monitoring.

Klinische Bedeutung

Elevated oxLDL levels indicate increased oxidative stress and are associated with a higher risk of atherosclerosis and cardiovascular diseases. Low levels are generally considered favorable, reflecting lower cardiovascular risk.

Dynamics

Trend Interpretation

Rising Values

Progressively rising oxLDL suggests worsening oxidative stress and increased cardiovascular risk. Retest in 3-6 months if elevated.

Falling Values

Falling oxLDL levels indicate improved oxidative balance and reduced cardiovascular risk.

Re-test Interval

6 months if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • High dietary intake of oxidized fats
  • Smoking
  • Metabolic syndrome
  • Diabetes
  • Chronic inflammation
Cause

Low Levels

  • Low oxidative stress
  • Healthy diet rich in antioxidants
  • Regular physical activity
  • Effective lipid-lowering therapy
Protocol

How to Optimize

Lever

Lifestyle

  • Regular aerobic exercise
  • Smoking cessation
  • Stress management
Lever

Nutrition

  • Diet rich in fruits and vegetables
  • Increased intake of omega-3 fatty acids
  • Reduction of trans fats
Lever

Supplementation

  • Vitamin E
  • Coenzyme Q10
  • Omega-3 fish oil

Note:

Consult a healthcare provider before starting any new supplement regimen.

Testing Guidelines

Fasting Not Required
Not Time-Sensitive

Testing Frequency

Annually for individuals at risk of cardiovascular disease.

Interfering Factors

  • Recent high-fat meal
  • Acute illness
  • Smoking

Related Peptides & Hormones

Il 6

Correlated with

hormone or peptide

Open Research Questions

Current research suggests that reference ranges and optimal targets for soluble LOX-1 as a biomarker for atherosclerosis remain undefined, with confounding factors such as metabolic syndrome and obesity not fully elucidated. Researchers have not yet established the precise role of genetic polymorphisms in modulating LOX-1-related disease risk. Additionally, clinical questions regarding the efficacy of LOX-1-targeted therapies and the long-term implications of elevated sLOX-1 levels in diverse populations remain unanswered.

23 Research Publications

1,084

Total Citations

6

Human/RCT

4.1

Avg. Influence

2025

Latest

Sort
Filter
#01

Scavenger receptors, oxidized LDL, and atherosclerosis.

In VitroInfluence13.0
345
Researchers studied the binding of oxidized LDL (oxLDL) to macrophages, revealing that oxidized phospholipids play a significant role in this process. They found that the persistence of receptors for oxLDL is crucial for recognizing damaged cells, which has implications for atherogenesis.
View on PubMed
#02

Oxidation of LDL and its clinical implication.

ReviewInfluence6.0
229
Researchers reviewed the clinical implications of oxidized LDL (oxLDL) in atherosclerosis, finding that oxLDL promotes inflammatory responses and foam cell formation. They noted that autoantibodies against oxLDL complexes may be linked to arterial thrombosis, highlighting the complex role of oxLDL in cardiovascular disease.
View on PubMed
#03

Oxidized LDL and NO synthesis--Biomarkers of endothelial dysfunction and ageing.

Gradinaru Daniela, et al. · Mechanisms of ageing and development · 2015

ReviewInfluence6.0
160
This review examined the relationship between oxidized LDL (oxLDL) and nitric oxide (NO) in endothelial dysfunction and aging. Researchers found that both oxLDL and NO serve as biomarkers for cardiovascular diseases and may reflect human biological age.

Key findings

  1. 01Researchers observed that metabolic health affects the levels of oxidized LDL and nitric oxide, which are linked to oxidative stress.
  2. 02The study indicates that oxidized LDL and nitric oxide can be used as biomarkers to predict cardiovascular outcomes in humans.
  3. 03Evidence suggests that these biomarkers are significant in understanding vascular aging and related diseases.
View on PubMed
#04

Challenges and advances in the management of inflammation in atherosclerosis.

Review
99
This review examined the role of inflammation in atherosclerosis, highlighting how immune cells like macrophages interact with oxidized LDL (oxLDL) to contribute to plaque formation. Researchers found that macrophages can ingest oxLDL, leading to foam cell formation, which is crucial for plaque stability. The study also discussed advancements in imaging and biomarkers that enhance understanding of disease progression.
View on PubMed
#05

Oxidative stress and organ damages.

Review
90
This review focused on oxidative stress and its role in various organ damages, including the impact of oxidized LDL (oxLDL). Researchers found that measuring oxidative stress, including oxLDL levels, may serve as a biomarker for organ dysfunction in conditions such as diabetes and hypertension.
View on PubMed
#06

LOX-1 in atherosclerotic disease.

HumanInfluence1.0
49
This study investigated the role of LOX-1 in atherosclerosis, finding that serum levels of LOX-1 ligand containing apoB (LAB) were positively associated with carotid intima-media thickness and coronary artery disease. Researchers observed that soluble LOX-1 (sLOX-1) could serve as a better biomarker for acute coronary syndrome than traditional markers.
View on PubMed
#07

LOX-1 and atherosclerotic-related diseases.

Review
47
Researchers explored the role of LOX-1 in atherosclerosis, noting that circulating levels of soluble LOX-1 (sLOX-1) are linked to plaque rupture and acute coronary syndrome. The study highlighted genetic polymorphisms of LOX-1 that may influence the risk of atherosclerotic diseases.
View on PubMed
#08

Clinical and Preclinical Use of LOX-1-Specific Antibodies in Diagnostics and Therapeutics.

ReviewInfluence1.0
13
Researchers reviewed the clinical applications of LOX-1-specific antibodies in diagnostics and therapeutics related to diseases like atherosclerosis. The study emphasized the need for further clinical studies to translate LOX-1 findings into effective patient care strategies.
View on PubMed
#09

Controversy over the atherogenicity of lipoprotein-X.

ReviewInfluence1.0
12
This review discussed the controversial role of lipoprotein-X (Lp-X) in atherosclerosis, noting its lipid composition similarities to LDL. Researchers found that Lp-X could lead to more lipid accumulation than oxidized LDL in macrophages, suggesting a complex relationship with atherogenicity.
View on PubMed
#10

Oxidized LDL receptors: a recent update.

ReviewInfluence1.0
9
Researchers reviewed recent findings on oxidized LDL (oxLDL) receptors, particularly LOX-1, and their role in atherosclerosis. They found that targeting the oxLDL-LOX-1 axis could lead to new therapeutic strategies. Additionally, soluble LOX-1 was identified as a potential biomarker for cardiovascular disease diagnosis and prognosis.
View on PubMed

Publication Trend

Research publications about Oxidiertes LDL over time

10total
1
'01
1
'14
2
'15
2
'19
1
'23
2
'24
1
'25

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer